ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study

Kuemmel, Sherko; Fasching, Peter A.; Schmid, Peter; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Boileau, Jean-Francois; Cortes, Javier; Dent, Rebecca; O'shaughnessy, Joyce; Pusztai, Lajos; Foukakis, Theodoros; Park, Yeon Hee; Hui, Rina; Cardoso, Fatima; Denkert, Carsten; Jia, Liyi; Pan, Wilbur; Karantza, Vassiliki; Mcarthur, Heather

doi:10.1245/s10434-026-19310-z

상세 보기

ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study

Kuemmel, Sherko;
Fasching, Peter A.;
Schmid, Peter;
Harbeck, Nadia;
Takahashi, Masato;
... Park, Yeon Hee;
외 14명

Citations

WEB OF SCIENCE

0

Citations

SCOPUS

0

제목: ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study

저자: Kuemmel, Sherko; Fasching, Peter A.; Schmid, Peter; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Boileau, Jean-Francois; Cortes, Javier; Dent, Rebecca; O'shaughnessy, Joyce; Pusztai, Lajos; Foukakis, Theodoros; Park, Yeon Hee; Hui, Rina; Cardoso, Fatima; Denkert, Carsten; Jia, Liyi; Pan, Wilbur; Karantza, Vassiliki; Mcarthur, Heather

DOI: 10.1245/s10434-026-19310-z

발행일: 2026-03-12

유형: Editorial Material; Early Access

저널명: Annals of Surgical Oncology

권: 33

호: 6

페이지: 5632 ~ 5634

ScholarWorks@성균관대학교

상세 보기